| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Recent advancements in pharmaceutical innovations are driving significant growth in drug development, particularly in treating obesity and diabetes. Eli Lilly is heavily invested in creating cutting-edge therapies that address these health issues, with a strong focus on clinical research and validation. The emphasis on innovative treatments is propelled by a growing market demand for effective healthcare solutions. As the pharmaceutical landscape evolves, Eli Lilly aims to remain at the forefront of these developments. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at -0.4 is modestly bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0, and the negative at -0.4 on 2025-04-08. The forces of Sentiment towards Fundamentals (-1.3), and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), and Market Risk Appetite (0) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-08 | 0%(0%) | 0 | 0% | -0.4 | -1.3 | -1 | |||||||
| 2025-04-07 | 0%(0%) | 0 | 0% | -0.6 | -2.4 | -1 | |||||||
| 2025-04-04 | 0%(0%) | 0 | 0% | -0.2 | -0.2 | -1 | |||||||
| 2025-04-03 | 0%(0%) | 0 | 0% | -0.3 | -0.6 | -1 | |||||||
| 2025-04-02 | 0%(0%) | 0 | 0% | -0.3 | -0.7 | -1 | |||||||
| 2025-04-01 | 0%(0%) | 0 | 0% | -0.2 | -0.3 | -1 | |||||||
| 2025-03-31 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| 2025-03-28 | 0%(0%) | 0 | 0% | -0 | 0.9 | -1 | |||||||
| 2025-03-27 | 0%(0%) | 0 | 0% | 0.1 | 1.4 | -1 | |||||||
| 2025-03-26 | 0%(0%) | 0 | 0% | 0.1 | 1.7 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-05-19 17:08:35 The increasing prevalence of diabetes and obesity is driving demand for effective treatments, positioning both LLY and NVO for potential success. |
| 2025-05-19 17:08:35 Analysts are providing insights into LLY’s market strategies, reflecting on its growth and performance relative to competitors. |
| 2025-05-19 17:08:35 Both companies are focusing on innovative drug development, particularly in the areas of weight-loss and diabetes treatment. |
| 2025-05-19 17:08:35 There is growing investor interest in Eli Lilly (LLY), indicating positive market sentiment towards its stock performance. |
| 2025-05-19 17:08:35 The competition between pharmaceutical companies LLY and NVO in the weight-loss drug market highlights their roles in developing diabetes and obesity treatments. |